Marshall Wace’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Marshall Wace’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,538	Closed	-$191K	–	3481
2022 Q4	$191K	Buy	+15,538	New	+$370K	﹤0.01%	2709

Marshall Wace's CINC Position: Q1 2023 in Review

Marshall Wace sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 15,538 shares — an estimated $191K sold.

Marshall Wace first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $191K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Marshall Wace reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Marshall Wace sold 15,538 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $191K.
Marshall Wace first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Marshall Wace's CinCor Pharma, Inc. Common Stock position peaked at $191K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.